2m 2m 2m 2m 2m 2m 2m
Viatris (VTRS)
NASDAQ
$16.17-$0.22 (-1.34%)
Price as of Jul 13, 2026 7:50 PM EDT- $18.9BMarket Cap
- 86.39%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Viatris (VTRS)
$16.17-$0.22 (-1.34%)
VTRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.39 | ||
Change | +$0.12 (+0.74%) | ||
Open | $16.29 | ||
High | $16.59 | ||
Low | $16.22 | ||
Previous Close | $16.27 | ||
Volume | 5,843,738 | ||
30-Day Average Volume | 10,339,698 | ||
1-Week Change | -2.44% | ||
1-Month Change | -0.55% | ||
1-Year Change | 86.39% | ||
3-Year Change | 81.28% | ||
5-Year Change | 45.31% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $36.8B | ||
Market Cap | $18.9B | ||
Enterprise Value | $31.5B | ||
Period: QTR TTM FY | |||
Revenue | $3.5B | ||
Net Income | $176.4M | ||
Free Cash Flow | $348.4M | ||
EBIT | -$127.2M | ||
EBITDA | $548.9M | ||
Net Working Capital | $4.1B | ||
EPS | $0.15 | ||
Enterprise Value/EBITDA | 57 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 1 | ||
P/E | 108 | ||
PEG | 1 | ||
Price/Free Cash Flow | 54 | ||
Price/Operating Cash Flow | 49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.93% | ||
Trailing Annual Dividend Yield | 2.93% | ||
Ex-Dividend Date | 05/22/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield